Familial Amyloid Cardiomyopathy is aprogressive disease, which affects millions of people worldwide andis characterized by the accumulation of nonfunctional proteins in thebody, most notably in the heart. The accumulation results in theaccumulation of lipid (fat) deposits that deposit within the affectedorgan, and eventually result in irreversible tissue damage. These fatdeposits gradually take control of the blood supply, causing anaccumulation of fluids around the heart, and ultimately causing aheart malfunction that results in death. Some other symptoms includesevere pain, decreased lung capacity, stiff neck, decreased vision,and speech problems. These complications may not develop in a patientwith Familial Amyloid Cardiomyopathy, and this disease only affectswomen of reproductive age.
Researchstudies have indicated that hereditary and stressful factors maycause this condition, but the exact mechanisms involved remainlargely unknown. It was also found that genetic diseases and stressare unlikely to be the only causes and that environmental factorssuch as smoking and alcohol consumption increase the risk ofdeveloping familial amyloid cardiomyopathy. It is important to notethat FamilialAmyloid Cardiomyopathy Treatment is a rapidly evolving field dueto the advent of advanced diagnostic techniques and advancedpharmaceuticals. It has been found that genetic variants of the APOEgene play a pivotal role in the development of familial amyloidcardiomyopathy, thereby suggesting that these variants may one dayprove to be a major determinant in the successful treatment andrecovery of patients affected with this condition. Vyndaqel is one ofthe common forms of drug used in Familial Amyloid CardiomyopathyTreatment. Biomed Central Journal has also conducted a studyexamining the efficacy of vyndaqel in familial amyloid cardiomyopathytreatment and found that patients taking vyndaqel as their mainmedication had significantly increased results compared to those whotook placebo. Vyndaqel is a novel anticoagulant agent that hasrecently been approved by the US Food and Drug Administration (FDA).
